European Union - English - EMA (European Medicines Agency)

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

European Union - English - EMA (European Medicines Agency)

sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antithrombotic agents - acute coronary syndromemyocardial infarction

European Union - English - EMA (European Medicines Agency)

mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antithrombotic agents - clopidogrel/acetylsalicylic acid mylan is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa).clopidogrel/acetylsalicylic acid mylan is a fixed-dose combination medicinal product for continuation of therapy in:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

United States - English - NLM (National Library of Medicine)

prugen, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 27.24 g in 1 g - salicylic acid 6% (w/w) cream is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders, including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). for podiatric use: salicylic acid 6% (w/w) cream is a topical aid in the removal of excessive keratin on the dorsal and plantar hyperkeratotic lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salicylic acid 6% (w/w) cream should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% (w/w) cream should not be used in children under 2 years of age.

United States - English - NLM (National Library of Medicine)

prugen llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 6 mg in 100 ml - salicylic acid 6% (w/w) shampoo is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders, including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). salicylic acid 6% (w/w) shampoo is a topical aid in the removal of excessive keratin on the dorsal and plantar hyperkeratotic lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salicylic acid 6% (w/w) shampoo should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% (w/w) shampoo should not be used in children under 2 years of age.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 6 g in 100 g - for dermatologic use: salicylic acid 6% foam is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders, including verrucae and the various ichthyoses, keratosis palmaris and plantaris, keratosis pilaris, pityriasis rubra pilaris and psoriasis. for podiatric use: salicylic acid 6% foam is a topical aid in the removal of excessive keratin on dorsal and plantar hyperkeratotic lesions. salicylic acid 6% foam should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% foam should not be used in children under 2 years of age.

United States - English - NLM (National Library of Medicine)

nationwide laboratories, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 6 g in 100 ml - for dermatologic  use: salicylic acid 6% is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae, and the various ichthyoses (vulgaris, sex-linked  and lamellar), keratosis palmaris and plantaris keratosis pilaris, pityriasis rubra pilaris, and  psoriasis (including body, scalp, palms and soles). for podiatric use: salicylic  acid 6% is a topical aid in the removal of excessive keratin on  dorsal and plantar hyperkeratotic  lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salicylic acid 6% should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% should not be used in children under 2 years of age.

United States - English - NLM (National Library of Medicine)

nationwide laboratories, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 6 g in 100 g - for dermatologic  use: salicylic acid 6% is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae, and the various ichthyoses (vulgaris, sex-linked  and lamellar), keratosis palmaris and plantaris keratosis pilaris, pityriasis rubra pilaris, and  psoriasis (including body, scalp, palms and soles). for podiatric use: salicylic  acid 6% is a topical aid in the removal of excessive keratin on  dorsal and plantar hyperkeratotic  lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. salicylic acid 6% should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% should not be used in children under 2 years of age.

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 60 mg in 1 g - indications and usage for the removal of excess keratin in hyperkeratotic disorders, including scaling associated with psoriasis or thickened skin of palms and soles, corns and calluses. contraindications salicylic acid 6% gel should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. salicylic acid 6% gel should not be used in children under 2 years of age.

United States - English - NLM (National Library of Medicine)

exact-rx, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - salicylic acid 60 mg in 1 g - for dermatologic use: sa 6% is a topical aid in the removal of excessive keratin in hyperkeratotic skin disorders including verrucae, and the various ichthyoses (vulgaris, sex-linked and lamellar), keratosis palmaris and plantaris keratosis pilaris, pityriasis rubra pilaris, and psoriasis (including body, scalp, palms and soles). for podiatric use: sa 6% is a topical aid in the removal of excessive keratin on dorsal and plantar hyperkeratotic lesions. topical preparations of 6% salicylic acid have been reported to be useful adjunctive therapy for verrucae plantares. sa 6% should not be used in any patient known to be sensitive to salicylic acid or any other listed ingredients. sa 6% should not be used in children under 2 years of age.